Abstract is: Plasmodium yoelii is a parasite of the genus Plasmodium subgenus Vinckeia. As in all Plasmodium species, P. yoelii has both vertebrate and insect hosts. The vertebrate hosts for this parasite are mammals.
taxon | Q16521 |
P6039 | Australian Faunal Directory ID | Plasmodium_yoelii |
P9272 | DeCS ID | 22964 |
P646 | Freebase ID | /m/0gxy2x |
P4333 | GenBank assembly accession number | GCA_900617845.1 |
GCA_900617855.1 | ||
GCA_900617865.1 | ||
GCA_900617875.1 | ||
GCA_900617885.1 | ||
P486 | MeSH descriptor ID | D010967 |
P672 | MeSH tree code | B01.043.075.380.611.780 |
P6366 | Microsoft Academic ID | 2776486806 |
P8189 | National Library of Israel J9U ID | 987007530570405171 |
P685 | NCBI taxonomy ID | 5861 |
P10283 | OpenAlex ID | C2776486806 |
P6800 | sequenced genome URL | https://protists.ensembl.org/Plasmodium_yoelii_17x_gca_000505035 |
https://protists.ensembl.org/Plasmodium_yoelii_gca_900002385 | ||
https://protists.ensembl.org/Plasmodium_yoelii_gca_900002395 | ||
https://protists.ensembl.org/Plasmodium_yoelii_yoelii_gca_000003085 | ||
P2892 | UMLS CUI | C0032155 |
P6104 | maintained by WikiProject | WikiProject Invasion Biology | Q56241615 |
P138 | named after | Meir Yoeli | Q20675603 |
P171 | parent taxon | Plasmodium | Q130948 |
P225 | taxon name | Plasmodium yoelii | |
P105 | taxon rank | species | Q7432 |
Q59946800 | Plasmodium yoelii reference genome |
Q59961561 | Py17X_01_v3 |
Q59964723 | Py17X_02_v3 |
Q59968205 | Py17X_03_v3 |
Q59971510 | Py17X_04_v3 |
Q59975143 | Py17X_05_v3 |
Q59979290 | Py17X_06_v3 |
Q59983583 | Py17X_07_v3 |
Q59987589 | Py17X_08_v3 |
Q59994104 | Py17X_09_v3 |
Q61615230 | Py17X_10_v3 |
Q61616450 | Py17X_11_v3 |
Q61617712 | Py17X_12_v3 |
Q61619005 | Py17X_13_v3 |
Q61620825 | Py17X_14_v3 |
Q61622576 | Py17X_API_v3 |
Q61622681 | Py17X_MIT_v3 |
Q41939134 | "Antimalarial" medicinal plants and their impact on cell populations in various organs of mice |
Q107153530 | 113 Effects of Plasmodium yoelii nigeriensis on the life cycle of infected hosts : 7. Evaluation of malaria transmission of Anopheles stephensi with different densities of oocyst |
Q42991396 | 6-(4'-Aryloxy-phenyl)vinyl-1,2,4-trioxanes: a new series of orally active peroxides effective against multidrug-resistant Plasmodium yoelii in Swiss mice |
Q52431784 | A Cas9 Transgenic Plasmodium yoelii parasite for efficient gene editing. |
Q38369060 | A Plasmodium yoelii HECT-like E3 ubiquitin ligase regulates parasite growth and virulence |
Q30041872 | A Plasmodium yoelii Mei2-Like RNA Binding Protein Is Essential for Completion of Liver Stage Schizogony |
Q37038432 | A Plasmodium yoelii soluble factor inhibits the phenotypic maturation of dendritic cells. |
Q47927313 | A Plasmodium yoelii yoelii erythrocyte binding protein that uses Duffy binding-like domain for invasion: a rodent model for studying erythrocyte invasion |
Q47858382 | A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei |
Q44167130 | A cage replacement experiment involving introduction of genes for refractoriness to Plasmodium yoelii nigeriensis into a population of Anopheles gambiae (Diptera: Culicidae). |
Q47943880 | A comparative account of the effects of betamethasone on mice infected with Plasmodium vinckei chabaudi and Plasmodium berghei yoelii |
Q47994541 | A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse |
Q47930879 | A comparison of the pyrimethamine and cycloguanil sensitivities of the pre-erythrocytic and erythrocytic stages of drug-sensitive and -resistant strains of Plasmodium yoelii |
Q40802478 | A cytoplasmic polyhedrosis virus in midgut cells of Anopheles stephensi and in the sporogonic stages of Plasmodium berghei yoelii |
Q42694270 | A gene coding for a high-molecular mass rhoptry protein of Plasmodium yoelii |
Q59394171 | A high molecular mass Plasmodium yoelii rhoptry protein binds to erythrocytes |
Q36790155 | A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein |
Q47217736 | A male gametocyte osmiophilic body and microgamete surface protein of the rodent malaria parasite Plasmodium yoelii (PyMiGS) plays a critical role in male osmiophilic body formation and exflagellation |
Q53633957 | A member of the py235 gene family of Plasmodium yoelii encodes an erythrocyte binding protein recognised by a protective monoclonal antibody. |
Q36469103 | A method for monitoring the viability of malaria parasites (Plasmodium yoelii) freed from the host erythrocytes |
Q36219507 | A new malaria antigen produces partial protection against Plasmodium yoelii challenge |
Q87838471 | A novel Plasmodium yoelii pseudokinase, PypPK1, is involved in erythrocyte invasion and exflagellation center formation. |
Q47880427 | A potent antimalarial activity of Hydrangea macrophylla var. Otaksa leaf extract against Plasmodium yoelii 17XL in mice |
Q47999803 | A preliminary study on the inhibitory action of target-primaqine on the exoerythrocytic forms of Plasmodium yoelii yoelii |
Q34004960 | A protective glycosylphosphatidylinositol-anchored membrane protein of Plasmodium yoelii trophozoites and merozoites contains two epidermal growth factor-like domains |
Q42074466 | A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii |
Q47888629 | A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii. |
Q44150910 | A rapid method for screening antibodies to Plasmodium yoelii liver stages by immunofluorescence |
Q33599911 | A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. |
Q47975132 | A screening method for tissue schizontocides with Plasmodium yoelii |
Q47994238 | A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice. |
Q44063713 | A spleen is not necessary to resolve infections with Plasmodium yoelii. |
Q47812680 | A study of selected Plasmodium yoelii messenger RNAs during hepatocyte infection. |
Q34004723 | A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture |
Q35893710 | A systematic analysis of the early transcribed membrane protein family throughout the life cycle of Plasmodium yoelii |
Q107153153 | A-15 Effects of Plasmodium yoelii nigeriensis on the life cycle of infected hosts. : 5. Infectivity and fate of sporozoites loaded in salivary glands of mosquitoes, Anopheles stephensi |
Q40101945 | ALBA4 modulates its stage-specific interactions and specific mRNA fates during Plasmodium yoelii growth and transmission |
Q37142838 | ATP/ADP binding to a novel nucleotide binding domain of the reticulocyte-binding protein Py235 of Plasmodium yoelii |
Q30986713 | Aberrations in cerebral vascular functions due to Plasmodium yoelii nigeriensis infection in mice |
Q44166556 | Absence of effects of insecticides on susceptibility of anophelines to Plasmodium yoelii nigeriensis. |
Q47848374 | Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. |
Q48029851 | Accumulation of major histocompatibility complex class II(+)CD11c(-) non-lymphoid cells in the spleen during infection with Plasmodium yoelii is lymphocyte-dependent. |
Q47959347 | Acquired immunity to Plasmodium berghei yoelii in mice |
Q36668561 | Active and passive immunization against Plasmodium yoelii sporozoites |
Q46937605 | Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations |
Q39325300 | Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection |
Q41943495 | Activities of new acridone alkaloid derivatives against Plasmodium yoelii in vitro |
Q35284671 | Activities of pefloxacin and ciprofloxacin against experimental malaria in mice |
Q67873765 | Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro |
Q38664665 | Adaptive immunity is essential in preventing recrudescence of Plasmodium yoelii malaria parasites after artesunate treatment |
Q44038657 | Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome. |
Q42073835 | Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria |
Q41929480 | Adoptive transfer of immunity induced with chloroquine attenuated Plasmodium yoelii nigeriensis from immune to immunologically naive mice. |
Q48025060 | Age-related susceptibility and resistance to nonlethal Plasmodium yoelii infection in C57BL/6 mice. |
Q40925477 | Alteration in the virulence of Plasmodium berghei yoelii for white mice by passage through golden hamsters and by the in vitro exposure to the serum of these animals |
Q47832700 | Amino acid transport in cerebral microvessels during Plasmodium yoelii infection in mice |
Q47926856 | An antigen of Plasmodium yoelii that translocates into the mouse erythrocyte membrane upon entry into the host cell |
Q37234938 | An early burst of IFN-gamma induced by the pre-erythrocytic stage favours Plasmodium yoelii parasitaemia in B6 mice |
Q44139988 | An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model |
Q44993455 | An immunogenic antigen of murine Plasmodium yoelii 17X associates with class I MHC glycoproteins |
Q69737986 | An increase in water content of mouse erythrocytes infected with Plasmodium yoelii |
Q47829157 | An unusual tryptophan-rich domain characterizes two secreted antigens of Plasmodium yoelii-infected erythrocytes. |
Q39173633 | Anaemia in mice with concomitant Schistosoma mansoni and Plasmodium berghei yoelii infection |
Q36045018 | Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination |
Q36625765 | Analysis of mRNA coding for blood-stage antigens of a rodent malarial parasite, Plasmodium yoelii: mRNA coding for a possible protective antigen purify as poly A-. |
Q41917633 | Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice |
Q35991786 | Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii |
Q50146201 | Anti-tumor effect of Plasmodium yoelii infection on melanoma in mice |
Q39537996 | Antibodies against ribosomal phosphoprotein P0 of Plasmodium falciparum protect mice against challenge with Plasmodium yoelii |
Q46172511 | Antibody formation to low-dose antigen and Plasmodium yoelii clearance by offspring of protein-depleted male and female mice |
Q47932097 | Antibody levels in mice infectedwith Plasmodium berghei yoelii |
Q36988658 | Antibody recognition and isoelectrofocusing of antigens of the malaria parasite Plasmodium yoelii |
Q34406100 | Antibody response in vitro of spleen cells from Plasmodium yoelii-infected mice |
Q34123568 | Antigen-presenting cell function during Plasmodium yoelii infection |
Q47864328 | Antigenic analysis of Plasmodium yoelii liver stages by fluorescence antibody assays. |
Q47986938 | Antimalarial activity of floxacrine (HOE 991) II: Studies on causal prophylactic and blood schizontocidal action of floxacrine and related dihydroacridinediones against Plasmodium yoelii and P. berghei. |
Q36588106 | Antimalarial activity of inhibitors of ADP-ribosyl transferase against Plasmodium yoelii infection in mice. 1. Preliminary data |
Q36987901 | Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii |
Q48001563 | Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo |
Q41945548 | Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis |
Q46746230 | Antimalarial efficacy of methylene blue and menadione and their effect on glutathione metabolism of Plasmodium yoelii-infected albino mice |
Q40217534 | Antimalarial efficacy, cytotoxicity, and genotoxicity of methanolic stem bark extract from Hintonia latiflora in a Plasmodium yoelii yoelii lethal murine malaria model |
Q41943509 | Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice |
Q43752313 | Antiplasmodial activity of artecyclopentyl mether a new artemisinin derivative and its effect on pathogenesis in Plasmodium yoelii nigeriensis infected mice |
Q37675338 | Apoptosis of non-parasitised red blood cells in Plasmodium yoelii malaria |
Q47996439 | Are antibodies important in mice infected with Plasmodium yoelii? |
Q61798900 | Are antibodies important in mice infected with Plasmodium yoelii? |
Q38916978 | Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: an approach by enhanced bioavailability |
Q101156183 | Artemisinin-Ginkgo biloba extract combination therapy for Plasmodium yoelii |
Q33927133 | Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection |
Q37283242 | Assessment and improvement of the Plasmodium yoelii yoelii genome annotation through comparative analysis |
Q37496763 | Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome |
Q40816394 | Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs |
Q41014518 | Assessment of real-time method to detect liver parasite burden under different experimental conditions in mice infected with Plasmodium yoelii sporozoites |
Q42215707 | Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii |
Q37608794 | Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. |
Q35632343 | Automated estimation of parasitaemia of Plasmodium yoelii-infected mice by digital image analysis of Giemsa-stained thin blood smears |
Q47988437 | B6 mice and Plasmodium yoelii. |
Q47945061 | Babesia microti and Plasmodium berghei yoelii infections in nude mice |
Q99201300 | Bacillus sphaericus exposure reduced vector competence of Anopheles dirus to Plasmodium yoelii by upregulating the Imd signaling pathway |
Q46389261 | Bacterial expression and purification of recombinant Plasmodium yoelii circumsporozoite protein |
Q41927043 | Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii |
Q44142271 | Blood digestion in the mosquito, Anopheles stephensi: the effects of Plasmodium yoelii nigeriensis on midgut enzyme activities |
Q41946744 | Blood schizontocidal activity of azithromycin and its combination with alpha/beta arteether against multi-drug resistant Plasmodium yoelii nigeriensis, a novel MDR parasite model for antimalarial screening |
Q48030862 | Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo |
Q48035220 | Both epidermal growth factor-like domains of the merozoite surface protein-1 from Plasmodium yoelii are required for protection from malaria |
Q34002308 | CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. |
Q47891355 | CD4+ T cells are required for HSP65 expression in host macrophages and for protection of mice infected with Plasmodium yoelii |
Q44220734 | CD4+ T cells play a major role for IgM and IgG anti-DNA production in mice infected with Plasmodium yoelii |
Q44235863 | CD4+CD25+Foxp3+ regulatory T cells prevent the development of Th1 immune response by inhibition of dendritic cell function during the early stage of Plasmodium yoelii infection in susceptible BALB/c mice. |
Q35189895 | CD47 regulates the phagocytic clearance and replication of the Plasmodium yoelii malaria parasite |
Q37581819 | CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii |
Q47863985 | CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria |
Q38998250 | CD81 is required for rhoptry discharge during host cell invasion by Plasmodium yoelii sporozoites |
Q40391112 | CRISPR/Cas9 mediated sequential editing of genes critical for ookinete motility in Plasmodium yoelii |
Q39171658 | CTLA-4 blockade differentially influences the outcome of non-lethal and lethal Plasmodium yoelii infections |
Q47966046 | Caspase‐12 deficiency enhances cytokine responses but does not protect against lethal Plasmodium yoelii 17XL infection |
Q41935690 | Causal preventive activity of standard antimalarials in rodent malaria (Plasmodium berghei yoelii) |
Q47832583 | Causal prophylactic activity of antihistaminic agents against Plasmodium yoelii nigeriensis infection in Swiss mice |
Q40213640 | Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro |
Q47908067 | Cellular subsets involved in cell-mediated immunity to murine Plasmodium yoelii 17X malaria |
Q47852138 | Cerebral ammonia levels and enzyme changes during Plasmodium yoelii infection in mice |
Q33916295 | Changes in parasite virulence induced by the disruption of a single member of the 235 kDa rhoptry protein multigene family of Plasmodium yoelii |
Q43660270 | Changes in rodent-erythrocyte methemoglobin reductase system produced by two malaria parasites, viz. Plasmodium yoelii nigeriensis and Plasmodium berghei |
Q39411906 | Changes in the spontaneous flight activity of the mosquito Anopheles stephensi by parasitization with the rodent malaria Plasmodium yoelii |
Q30765884 | Characterisation of the rhoph2 gene of Plasmodium falciparum and Plasmodium yoelii |
Q47984965 | Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen. |
Q47975141 | Characterization of Plasmodium yoelii antigens by monoclonal antibodies. II. In vivo assay of the protective effect of monoclonal antibodies |
Q28304173 | Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens |
Q47240632 | Characterization of a high molecular weight protective antigen of Plasmodium yoelii |
Q44518847 | Characterization of liver lymphomyeloid cells in mice infected with Plasmodium yoelii sporozoites. |
Q47997582 | Characterization of surface proteins and glycoproteins on red blood cells from mice infected with haemosporidia: Plasmodium yoelii infections of BALB/c mice. |
Q42607482 | Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen |
Q47857273 | Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii |
Q37129874 | Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection |
Q47900309 | Chromosomal mapping of the host resistance locus to rodent malaria (Plasmodium yoelii) infection in mice |
Q47847820 | Chromosomal organisation of a gene family encoding rhoptry proteins in Plasmodium yoelii |
Q40985559 | Chronic malarial infection of mice: a comparison of single and multiple infections with Plasmodium berghei following P. yoelii |
Q47985538 | Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice |
Q42647580 | Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii |
Q36683759 | Cloning and structural analysis of the gene for cAMP-dependent protein kinase catalytic subunit from Plasmodium yoelii |
Q46896808 | Cloning of Plasmodium yoelii genes expressing three different sporozoite-specific antigens |
Q30039212 | Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family |
Q41941185 | Comparative evaluation of blood schizontocidal activity of quinine and quinidine against drug resistant rodent malaria |
Q47992993 | Comparative histopathology of mice infected with the 17XL and 17XNL strains of Plasmodium yoelii |
Q46813585 | Comparative study between non lethal and lethal strains of Plasmodium yoelii with reference to its immunological aspect. |
Q44152915 | Comparative susceptibilities of Anopheles quadrimaculatus mutants to Plasmodium yoelii |
Q39407722 | Comparative susceptibility of two forms of Anopheles sinensis Wiedemann 1828 (Diptera : Culicidae) to infection with Plasmodium falciparum, P. vivax, P. yoelii and the determination of misleading factor for sporozoite identification. |
Q48037075 | Comparison of Plasmodium yoelii ookinete surface antigens with human and avian malaria parasite homologues reveals two highly conserved regions |
Q44486837 | Comparison of antimalarial activity of the alkaloidal fraction of Hydrangea macrophylla var. Otaksa leaves with the hot-water extract in ICR mice infected with Plasmodium yoelii 17 XL. |
Q69558408 | Comparison of fast (one-step) and interrupted slow cooling methods using a range of intracellular and extracellular cryoprotectants for the freeze-preservation of Plasmodium yoelii-infected mouse erythrocytes |
Q47838036 | Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite. |
Q35551948 | Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii |
Q48169677 | Comparison of the carboxy-terminal, cysteine-rich domain of the merozoite surface protein-1 from several strains of Plasmodium yoelii |
Q47889160 | Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii |
Q48066403 | Comparison of two members of a multigene family coding for high-molecular mass rhoptry proteins of Plasmodium yoelii |
Q34530656 | Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2. |
Q44078968 | Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with a |
Q36774490 | Complex transcription from the extrachromosomal DNA encoding mitochondrial functions of Plasmodium yoelii |
Q34302273 | Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA |
Q39949752 | Concurrent infection with Heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4(+)CD25(+)Foxp3(+) Treg in mice. |
Q48378786 | Conserved regions of the Plasmodium yoelii rhoptry protein RhopH3 revealed by comparison with the P. falciparum homologue |
Q99350489 | Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage |
Q47112430 | Conventional CD11chigh Dendritic Cells Are Important for T Cell Priming during the Initial Phase of Plasmodium yoelii Infection, but Are Dispensable at Later Time Points |
Q61651651 | Correction: Resistance of regulatory T cells to glucocorticoid-induced TNFR family-related protein (GITR) duringPlasmodium yoelii infection |
Q37036476 | Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug. |
Q38787400 | Correlation between in vitro and in vivo antimalarial activity of compounds using CQ-sensitive and CQ-resistant strains of Plasmodium falciparum and CQ-resistant strain of P. yoelii. |
Q47842059 | Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. |
Q37425131 | Corrigendum: Proteome mapping of Plasmodium: identification of the P. yoelii remodellome |
Q36740447 | Counter-regulatory anti-parasite cytokine responses during concurrent Plasmodium yoelii and intestinal helminth infections in mice |
Q44473027 | CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-ba |
Q56361380 | Critical role of Erythrocyte Binding-Like protein of the rodent malaria parasite Plasmodium yoelii to establish an irreversible connection with the erythrocyte during invasion |
Q34204920 | Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites |
Q34387264 | Crystallographic studies of the coupling segment NBD94(674-781) of the nucleotide-binding domain of the Plasmodium yoelii reticulocyte-binding protein Py235. |
Q44146502 | Cytofluorimetric analysis of DNA content in different life stages of Plasmodium yoelii |
Q36826340 | Cytofluorograf detection of Plasmodium yoelii, Trypanosoma gambiense, and Trypanosoma equiperdum by laser excited fluorescence of stained rodent blood |
Q45037496 | Cytokine and antibody production during the course of resolution in Plasmodium yoelii 17XL-infected BALB/c mice treated with febrifugine and isofebrifugine mixture from leaves of Hydrangea macrophylla var. Otaksa |
Q36729264 | Cytokine dysregulation associated with malarial anemia in Plasmodium yoelii infected mice |
Q66914441 | Cytology and Kinetics of microgametogenesis and fertilization in Plasmodium yoelii nigeriensis |
Q40294312 | DC-Derived IL-10 Modulates Pro-inflammatory Cytokine Production and Promotes Induction of CD4+IL-10+ Regulatory T Cells during Plasmodium yoelii Infection |
Q34006136 | DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge |
Q35009202 | Daily Plasmodium yoelii infective mosquito bites do not generate protection or suppress previous immunity against the liver stage |
Q41633131 | Defective resistance to Plasmodium yoelii in CBA/N mice |
Q41028358 | Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria |
Q102334195 | Definition of constitutive and stage-enriched promoters in the rodent malaria parasite, Plasmodium yoelii |
Q33286186 | Delineation of epitopes on the Py235 rhoptry antigen of Plasmodium yoelii YM. |
Q41404900 | Dendritic cells subsets mediated immune response during Plasmodium berghei ANKA and Plasmodium yoelii infection |
Q36631393 | Depletion of Phagocytic Cells during Nonlethal Plasmodium yoelii Infection Causes Severe Malaria Characterized by Acute Renal Failure in Mice |
Q40960476 | Detection of Plasmodium berghei and Plasmodium yoelii Liver-Stage Parasite Burden by Quantitative Real-Time PCR. |
Q47878791 | Detection of Plasmodium yoelii stage mRNA in BALB/c mice |
Q57460393 | Detection of host pathways universally inhibited after Plasmodium yoelii infection for immune intervention |
Q39003785 | Dietary fish oils and long‐term malaria protection in mice |
Q50722190 | Differences in the copy number of the py235 gene family in virulent and avirulent lines of Plasmodium yoelii. |
Q92246119 | Different doses of vitamin C supplementation enhances the Th1 immune response to early Plasmodium yoelii 17XL infection in BALB/c mice |
Q44486848 | Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice |
Q39324279 | Differential Induction of TGF-β Regulates Proinflammatory Cytokine Production and Determines the Outcome of Lethal and NonlethalPlasmodium yoeliiInfections |
Q64065320 | Differential Sensitivity to Plasmodium yoelii Infection in C57BL/6 Mice Impacts Gut-Liver Axis Homeostasis |
Q33997771 | Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. |
Q40075854 | Differential gene expression in Anopheles stephensi following infection with drug-resistant Plasmodium yoelii |
Q37509729 | Differential immune response associated to malaria outcome is detectable in peripheral blood following Plasmodium yoelii infection in mice |
Q47861512 | Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii |
Q112647355 | Dissecting Plasmodium yoelii Pathobiology: Proteomic Approaches for Decoding Novel Translational and Post-Translational Modifications |
Q110697494 | Distinct effects on the secretion of MTRAP and AMA1 in Plasmodium yoelii following deletion of acylated pleckstrin homology domain-containing protein |
Q47942979 | Distinct host-related dendritic cell responses during the early stage of Plasmodium yoelii infection in susceptible and resistant mice |
Q47883904 | Distribution and characterisation of the 235 kDa rhoptry multigene family within the genomes of virulent and avirulent lines of Plasmodium yoelii |
Q47925879 | Distribution of immunoglobulin isotypes in the nonspecific B-cell response induced by infection with Plasmodium chabaudi adami and Plasmodium yoelii |
Q73327770 | Docetaxel (Taxotere): effectiveness against Plasmodium falciparum in vitro and Plasmodium yoelii nigeriensis in vivo |
Q47990409 | Duffy antigen is important for the lethal effect of the lethal strain of Plasmodium yoelii 17XL. |
Q33815806 | Dynamic balance of pSTAT1 and pSTAT3 in C57BL/6 mice infected with lethal or nonlethal Plasmodium yoelii |
Q110697614 | E3 ubiquitin ligase RNF123-deficient mice exhibit reduced parasitemia and mortality in rodent malaria (Plasmodium yoelii 17XL) infection |
Q34004922 | Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria |
Q41616183 | Early treatment with chloroquine inhibits the immune response against Plasmodium yoelii infection in mice |
Q43772817 | Effect of PABA and sulphadiazine on two pyrimethamine-resistant Plasmodium berghei yoelii lines |
Q41935444 | Effect of PABA on Chloroquine Resistance in Plasmodium berghei yoelii |
Q37075496 | Effect of Plasmodium yoelii exposure on vaccination with the 19-kilodalton carboxyl terminus of merozoite surface protein 1 and vice versa and implications for the application of a human malaria vaccine |
Q41944049 | Effect of Plasmodium yoelii infection on GABA metabolism of mouse brain |
Q44140128 | Effect of Plasmodium yoelii nigeriensis (Haemosporidia: Plasmodiidae) on Anopheles stephensi (Diptera: Culicidae) vitellogenesis |
Q41913505 | Effect of Plasmodium yoelii nigeriensis infection and chloroquine on the hepatic mixed function oxidase system of mice |
Q42164509 | Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy |
Q43613191 | Effect of beta-arteether treatment on erythrocytic methemoglobin reductase system in Plasmodium yoelii nigeriensis infected mice |
Q35925680 | Effect of chloroquine on gene expression of Plasmodium yoelii nigeriensis during its sporogonic development in the mosquito vector |
Q41926000 | Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis |
Q44669554 | Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection |
Q47907150 | Effect of dihydroquinghaosu on the development of Plasmodium yoelii yoelii in Anopheles stephensi |
Q44896546 | Effect of host-diet inadequacy on the course of infection of plasmodium yoelii Nigeriensis. |
Q41943042 | Effect of ketotifen on the ultrastructure of the erythrocytic stages of Plasmodium yoelii |
Q69047512 | Effect of nitroquine (CL-679) in vitro on incorporation of [3H]hypoxanthine into DNA and RNA of Plasmodium yoelii |
Q47922175 | Effect of nitroquine on the membrane phospholipid of intraerythrocytic Plasmodium yoelii in vitro |
Q43564398 | Effect of poly ICLC treatment on hepatic oxidative stress and antioxidant defense indices in Plasmodium yoelii nigeriensis infected mice. |
Q67838917 | Effect of sodium artesunate on Plasmodium yoelii analysed by flow cytometry |
Q41911952 | Effect of stress conditions on the course of trophozoite-induced Plasmodium yoelii nigeriensis in mice recently cured of a previous infection |
Q68080886 | Effect of temperature on erythrocyte-free Plasmodium yoelii |
Q36804164 | Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity |
Q48002443 | Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages |
Q45403301 | Effects of CD4(+)CD25(+)Foxp3(+)regulatory T cells on early Plasmodium yoelii 17XL infection in BALB/c mice |
Q127077343 | Effects of Iron Status and Iron Supplementation on Salmonella Typhimurium and Plasmodium Yoelii Infection In Mice |
Q42984996 | Effects of Plasmodium yoelii nigeriensis infection on Anopheles stephensi egg development and resorption |
Q107152948 | Effects of Plasmodium yoelii nigeriensis infection on fluctuations in blood-feeding activity of Anopheles stephensi |
Q107153460 | Effects of Plasmodium yoelii nigeriensis on the life cycle of infected hosts : 6. Development of infectivity and fate of sporozoites |
Q41941327 | Effects of alpha-dimethylamino-cyclohexoxyl-dimethyl gallium on ultrastructure of erythrocytic stage of Plasmodium berghei and P yoelii |
Q41936814 | Effects of four drugs on intraerythrocytic Plasmodium yoelii of early and late stages |
Q39142464 | Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection |
Q71360768 | Effects of iron deficiency on the hepatic development of Plasmodium yoelii |
Q107152919 | Effects of malaria infection in Anopheles stephensi mosquitoes on passage through a wide-mesh net |
Q47848785 | Effects of nitroquine on ultrastructures and cytochrome oxidase of exoerythrocytic Plasmodium yoelii in rat liver |
Q107152886 | Effects of oocyst number of Plasmodium yoelii nigeriensis on activities of infected mosquitoes |
Q45035077 | Effects of pyran copolymer on host resistance of mice to Plasmodium yoelii |
Q34147295 | Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission |
Q37160241 | Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii |
Q41930036 | Efficacy of Cymbopogon giganteus and Enantia chrantha against chloroquine resistant Plasmodium yoelii nigeriensis. |
Q39143956 | Efficient control of Plasmodium yoelii infection in BALB/c and C57BL/6 mice with pre-existing Strongyloides ratti infection. |
Q44162826 | Electron microscope studies on motile stages of malaria parasites. VI. The oökinete of Plasmodium berghei yoelii and its transformation into the early oöcyst |
Q34309728 | Elevated Levels of thePlasmodium yoeliiHomologue of Macrophage Migration Inhibitory Factor Attenuate Blood-Stage Malaria |
Q47994387 | Elevated levels of phospholipase B in mice infected and challenged with Plasmodium yoelii |
Q55215396 | Elevated plasma abscisic acid is associated with asymptomatic falciparum malaria and with IgG-/caspase-1-dependent immunity in Plasmodium yoelii-infected mice. |
Q69423364 | Elucidation of the receptors in macrophage and Plasmodium yoelii interactions |
Q70250132 | Endoprotease in Plasmodium yoelii nigeriensis |
Q59068606 | Enhanced expression of H–2K and H–2D antigens on reticulocytes infected with Plasmodium yoelii |
Q47982922 | Enhanced parasitization of platelets by Plasmodium berghei yoelii |
Q27973703 | Enzymes involved in plastid-targeted phosphatidic acid synthesis are essential for Plasmodium yoelii liver-stage development |
Q41727600 | Ependymal damage in a Plasmodium yoelii yoelii lethal murine malaria model |
Q47889644 | Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells |
Q48015971 | Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice |
Q35166501 | Etiopathogenesis of Burkitt's lymphoma: a lesson from a BL-like in CD1 mouse immune to Plasmodium yoelii yoelii |
Q47835462 | Eurycoma longifolia extract-artemisinin combination: parasitemia suppression of Plasmodium yoelii-infected mice. |
Q98895054 | Evaluation of the genotoxicity, cytotoxicity and antimalarial effect of sodium metavanadate po in a Plasmodium yoelii yoelii infected murine model |
Q36668571 | Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene |
Q50908139 | Evasion of macrophage microbicidal mechanisms by mature sporozoites of Plasmodium yoelii yoelii. |
Q28481379 | Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs |
Q48036688 | Exacerbation of Plasmodium yoelii malaria in Echinostoma caproni infected mice and abatement through anthelmintic treatment |
Q34064539 | Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections. |
Q43712807 | Experimental infections of Plasmodium yoelii nigeriensis in mice and rats, and hosts' reactions |
Q47997309 | Experimental production of variants with lowered preference for polychromatophilic erythrocytes in Plasmodium yoelii (author's transl) |
Q47882976 | Experimental transfer of immunity to Plasmodium yoelii nigeriensis from adult rats to baby rats |
Q107152814 | Experimental transmission of Plasmodium yoelii nigeriensis by Anopheles omorii (Diptera : Culicidae) |
Q64902150 | Experimentally derived, stable mefloquine resistance in Plasmodium yoelii nigeriensis. |
Q39284969 | Expression and localization of rhoptry neck protein 5 in merozoites and sporozoites of Plasmodium yoelii |
Q47845892 | Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains |
Q44186148 | Expression of non-TLR pattern recognition receptors in the spleen of BALB/c mice infected with Plasmodium yoelii and Plasmodium chabaudi chabaudi AS. |
Q33194145 | Expression profiles of peroxiredoxin proteins of the rodent malaria parasite Plasmodium yoelii |
Q48032825 | Expression, localization, and erythrocyte binding activity of Plasmodium yoelii merozoite surface protein-8. |
Q35980267 | Extracellular ATP triggers proteolysis and cytosolic Ca²⁺ rise in Plasmodium berghei and Plasmodium yoelii malaria parasites. |
Q45221530 | FRET peptides reveal differential proteolytic activation in intraerythrocytic stages of the malaria parasites Plasmodium berghei and Plasmodium yoelii |
Q60621697 | Faculty of 1000 evaluation for Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity |
Q90681084 | Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoelii |
Q44458194 | Function of TEP1 gene during Plasmodium yoelii infection in Anopheles dirus |
Q37284860 | Functional Characteristics of the Gut Microbiome in C57BL/6 Mice Differentially Susceptible to Plasmodium yoelii |
Q47902450 | Gametocyte-dominant expression of a novel P-type ATPase in Plasmodium yoelii |
Q36531022 | Gametogenesis and fertilization in Plasmodium yoelii nigeriensis : a transmission electron microscope study |
Q37154484 | Gene encoding erythrocyte binding ligand linked to blood stage multiplication rate phenotype in Plasmodium yoelii yoelii |
Q47924321 | Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice. |
Q48224675 | Gene structure and ookinete expression of the chitinase genes of Plasmodium vivax and Plasmodium yoelii |
Q43569855 | Gene targeting in the rodent malaria parasite Plasmodium yoelii |
Q92770566 | Generation and functional characterisation of Plasmodium yoelii csp deletion mutants using a microhomology-based CRISPR/Cas9 method |
Q56359511 | Generation of Plasmodium yoelii malaria parasite carrying double fluorescence reporters in gametocytes |
Q104286677 | Generation of Plasmodium yoelii malaria parasite for conditional degradation of proteins |
Q44979627 | Genetic control of immunity to Plasmodium yoelii sporozoites |
Q36668581 | Genetic restriction of protective immunity to Plasmodium yoelii sporozoites. |
Q47915686 | Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes |
Q47974552 | Genetics of cross-resistance between antifolate drugs in Plasmodium yoelii. |
Q22122512 | Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii |
Q112723395 | Genome sequence, transcriptome, and annotation of rodent malaria parasite Plasmodium yoelii nigeriensis N67 |
Q35904552 | Genome-wide Analysis of Host-Plasmodium yoelii Interactions Reveals Regulators of the Type I Interferon Response. |
Q33737114 | Genome-wide polymorphisms and development of a microarray platform to detect genetic variations in Plasmodium yoelii |
Q47877744 | Glucose transport in cerebral microvessels during Plasmodium yoelii nigeriensis infection in mice |
Q44456240 | Glycosylphosphatidyl-inositols in murine malaria: Plasmodium yoelii yoelii |
Q47979767 | Growth and decline of parasitemia in trophozoite-induced Plasmodium berghei and Plasmodium yoelii infection in mice |
Q37548171 | HLA class II (DR0401) molecules induce Foxp3+ regulatory T cell suppression of B cells in Plasmodium yoelii strain 17XNL malaria |
Q28217666 | Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity |
Q47909163 | Heterologous synergistic interactions in concurrent experimental infection in the mouse with Schistosoma mansoni, Echinostoma revolutum, Plasmodium yoelii, Babesia microti, and Trypanosoma brucei |
Q47984697 | Histopathology and histochemistry of R.E.S. in infections with Plasmodium yoelii nigeriensis |
Q34078584 | Host defenses in murine malaria: evaluation of the mechanisms of immunity to Plasmodium yoelii infection |
Q33897628 | Host defenses in murine malaria: immunological characteristics of a protracted state of immunity to Plasmodium yoelii |
Q47865199 | Host resistance to murine malaria in mice exposed to the adenosine deaminase inhibitor, 2′-deoxycoformycin |
Q31838640 | Host responses to Plasmodium yoelii hepatic stages: a paradigm in host-parasite interaction |
Q39520665 | Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo |
Q57261130 | Human-applicable dendrigraft poly-l-lysine-based nanoparticle-coated Plasmodium yoelii-transamidase DNA vaccine is immunogenic and protective as the polyethylenimine-based formulation |
Q37453364 | Hundreds of microsatellites for genotyping Plasmodium yoelii parasites |
Q33867200 | IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model |
Q40124331 | IL-17 Promotes Differentiation of Splenic LSK- Lymphoid Progenitors into B Cells following Plasmodium yoelii Infection. |
Q37169633 | IL-18-induced expression of high-affinity IL-2R on murine NK cells is essential for NK-cell IFN-γ production during murine Plasmodium yoelii infection |
Q99928989 | IN VITRO CULTIVATION OF PLASMODIUM YOELII SPOROZOITES AT EXOERYTHROCYTIC STAGE FORM |
Q33361102 | Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection |
Q48028231 | Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. |
Q47968897 | Identification and expression analysis of ABC genes in Plasmodium yoelii and P. berghei |
Q40720795 | Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria |
Q46918126 | Identification of a new export signal in Plasmodium yoelii: identification of a new exportome. |
Q42612308 | Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa |
Q34304841 | Identification of the gene for a Plasmodium yoelii rhoptry protein. Multiple copies in the parasite genome |
Q47909112 | Igh-C allotype-linked control of anti-DNA production and clonotype expression in mice infected with Plasmodium yoelii. |
Q47995011 | Immediate inhibition of the infectivity of gametocytes of Plasmodium yoelii nigeriensis by serum from rodents infected for 5 days |
Q47997781 | Immune phagocytosis of Plasmodium yoelii-infected erythrocytes by macrophages and eosinophils. |
Q90381959 | Immune responses in liver and spleen against Plasmodium yoelii pre-erythrocytic stages in Swiss mice model |
Q47867346 | Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis |
Q45044633 | Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii |
Q44647791 | Immunity of peritoneal monocytes against Plasmodium yoelii infected erythrocytes |
Q39792439 | Immunity to Plasmodium Berghei yoelii in mice. I. The course of infection in T cell and B cell deficient mice |
Q39501642 | Immunity to Plasmodium berghei yoelii in mice. II. Specific and nonspecific cellular and humoral responses during the course of infection |
Q36674766 | Immunity to Plasmodium yoelii and Babesia microti: modulation by the CBA/N X-chromosome |
Q47917354 | Immunity to Plasmodium yoelii: kinetics of the generation of T and B lymphocytes that passively transfer protective immunity against virulent challenge |
Q48037488 | Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. |
Q36992482 | Immunization of mice against blood-stage Plasmodium yoelii malaria with isoelectrically focused antigens and correlation of immunity with T-cell priming in vivo |
Q34440997 | Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria |
Q43685660 | Immunization to produce a transmission-blocking immunity in Plasmodium yoelii malaria infections |
Q34258733 | Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii. |
Q35557454 | Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge |
Q40904213 | Immunization with hybrid hepatitis B virus core particles carrying circumsporozoite antigen epitopes protects mice against Plasmodium yoelii challenge. |
Q34004431 | Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection |
Q33593204 | Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge |
Q36053587 | Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection |
Q47945957 | Immunodepression vis-a-vis anti-whooping cough vaccine in mice infested with Plasmodium berghei yoelii |
Q70694096 | Immunoelectrophoretic analysis of erythrocytic stages of Plasmodium yoelii and P. chabaudi |
Q34301004 | Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice |
Q34007894 | Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice |
Q34109763 | Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii |
Q38447138 | Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants |
Q37505400 | Immunogenicity, protective efficacy and safety of a recombinant DNA vaccine encoding truncated Plasmodium yoelii sporozoite asparagine-rich protein 1 (PySAP1). |
Q34004484 | Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors |
Q47982602 | Immunoglobulin isotype distribution of malaria-specific antibodies produced during infection with Plasmodium chabaudi adami and Plasmodium yoelii |
Q47845766 | Immunological studies in rodent malaria. I: Protective immunity induced in mice by mild strains of Plasmodium berghei yoelii against a virulent and fatal line of this plasmodium |
Q41940788 | Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice. |
Q41943841 | Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice. |
Q42658177 | Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes |
Q46927846 | Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii |
Q44998206 | Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols |
Q47888282 | In vitro antibody response to the tetrapeptide repeats of Plasmodium falciparum circumsporozoite protein by splenocytes from mice infected with P. yoelii yoelii |
Q43806992 | In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials |
Q70712457 | In vitro culture of Plasmodium yoelii blood stages |
Q33307172 | In vitro observation on effect of nitric oxide on exflagellation of Plasmodium yoelii |
Q48009313 | In vitro survival and retention of infectivity of Plasmodium yoelii sporozoites over extended periods of time. |
Q27310073 | In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice |
Q41938835 | In vivo antimalarial activity of leaves of Plectranthus amboinicus (lour) spreng on Plasmodium berghei yoelii |
Q53851512 | In vivo antiparasitic activity of the Thai traditional medicine plant--Tinospora crispa--against Plasmodium yoelii. |
Q30577921 | In vivo splenic clearance correlates with in vitro deformability of red blood cells from Plasmodium yoelii-infected mice |
Q47916051 | Inbred mice infected with Plasmodium yoelii differ in their antimalarial immunoglobulin isotype response |
Q41930043 | Induction of chloroquine resistance in Plasmodium yoelii nigeriensis. |
Q48021710 | Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites. |
Q48006307 | Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. |
Q48037460 | Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. |
Q48001684 | Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. |
Q48007431 | Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine |
Q47994336 | Infection of mice concurrently with Schistosoma mansoni and rodent malarias: contrasting effects of patent S. mansoni infections on Plasmodium chabaudi, P. yoelii and P. berghei |
Q43817542 | Influence of Plasmodium berghei yoelii or P. chabaudi or both on the course of splenomegaly and immunoglobulins in mice |
Q57240638 | Influence of glycosylphosphatidylinositol anchorage on the efficacy of DNA vaccines encoding Plasmodium yoelii merozoite surface protein 4/5 |
Q44919023 | Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte |
Q46818542 | Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic benefits |
Q47823709 | Inhibition of the development of Plasmodium yoelii in exoerythrocytic stage in rodents (rats) with Chrysanthemum morifolium |
Q47858470 | Inhibition of the development of the hepatic stages of Plasmodium yoelii nigeriensis by antihistaminic agents |
Q43856282 | Inhibition of the immune response to pertussis vaccine during Plasmodium berghei yoelii infection in mice. |
Q47982707 | Inhibitory effect of rhodamine 123 on the growth of the rodent malaria parasite, Plasmodium yoelii |
Q43979196 | Inhibitory role of toll-like receptors agonists in Plasmodium yoelii liver stage development. |
Q31571046 | Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis |
Q47909871 | Interactions between Plasmodium yoelii and Leishmania mexicana amazonensis in Leishmania resistant C57B1/6 mice |
Q42992600 | Interactions between malaria (Plasmodium yoelii) and leishmaniasis (Leishmania mexicana amazonensis): effect of concomitant infection on host activity, host body temperature, and vector engorgement success |
Q47974605 | Interactions between the intestinal flagellates Giardia muris and Spironucleus muris and the blood parasites Babesia microti, Plasmodium yoelii and Plasmodium berghei in mice |
Q34461933 | Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity |
Q47837375 | Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice |
Q47925938 | Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain |
Q44146800 | Involvement of prophenoloxidases in the suppression of Plasmodium yoelii development by Anopheles dirus |
Q43666530 | Iron overload increases hepatic development of Plasmodium yoelii in mice |
Q40129832 | Isolation and Characterization of Vaccine Candidate Genes Including CSP and MSP1 in Plasmodium yoelii |
Q33331679 | Isolation and antimalarial activity of new morphinan alkaloids on Plasmodium yoelii liver stage. |
Q39284963 | Isolation of invasive Plasmodium yoelii merozoites with a long half-life to evaluate invasion dynamics and potential invasion inhibitors |
Q47795087 | Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies |
Q39534069 | Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis |
Q37098283 | Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst |
Q58853161 | Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin |
Q41953013 | Kinetics of antigen specific and non-specific polyclonal B-cell responses during lethal Plasmodium yoelii malaria |
Q48035135 | Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver |
Q35746442 | L-Arginine supplementation in mice enhances NO production in spleen cells and inhibits Plasmodium yoelii transmission in mosquitoes |
Q47991800 | L-arginine enhances Th1 immune response against Plasmodium yoelii 17XL infection in DBA/2 mice via activation of dendritic cells |
Q30802159 | Laser capture microdissection and molecular analysis of Plasmodium yoelii liver-stage parasites |
Q38615528 | Lethal Plasmodium yoelii malaria: the role of macrophages in normal and immunized mice |
Q33754121 | Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection |
Q47826234 | Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. |
Q35149755 | Linkage maps from multiple genetic crosses and loci linked to growth-related virulent phenotype in Plasmodium yoelii |
Q34003924 | Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19). |
Q47998943 | Linker-based hemisuccinate derivatives of artemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice |
Q45179863 | Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection |
Q36668575 | Localization of CS and non-CS antigens in the sporogonic stages of Plasmodium yoelii |
Q35783529 | Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice |
Q42223727 | MAPK phosphotase 5 deficiency contributes to protection against blood-stage Plasmodium yoelii 17XL infection in mice |
Q36190091 | Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection |
Q42937880 | Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen, and blood |
Q36314029 | Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia |
Q47852008 | Macrophages expressing heat-shock protein 65 play an essential role in protection of mice infected with Plasmodium yoelii |
Q41102159 | Malaria plasmodia in the mouse. Parasitization of mature and immature erythrocytes by Plasmodium berghei, Plasmodium yoelii and Plasmodium chabaudi (author's transl) |
Q112282251 | Mast Cell Chymase/Mcpt4 Suppresses the Host Immune Response to Plasmodium yoelii, Limits Malaria-Associated Disruption of Intestinal Barrier Integrity and Reduces Parasite Transmission to Anopheles stephensi |
Q40960483 | Measurement of Antibody-Mediated Reduction of Plasmodium yoelii Liver Burden by Bioluminescent Imaging |
Q40065575 | Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model |
Q33978709 | Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii |
Q43787492 | Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. |
Q47898413 | Mechanisms of splenic control of murine malaria: tissue culture studies of the erythropoietic interplay of spleen, bone marrow, and blood in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice |
Q35549892 | Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria |
Q98950199 | Memory CD73+IgM+ B cells protect against Plasmodium yoelii infection and express Granzyme B |
Q47874678 | Mercury exposure and murine response to Plasmodium yoelii infection and immunization |
Q34183154 | Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii |
Q38329970 | Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice |
Q47856201 | Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain |
Q46211758 | Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii |
Q41217736 | Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo |
Q28540099 | Modulation of Anopheles stephensi gene expression by nitroquine, an antimalarial drug against Plasmodium yoelii infection in the mosquito |
Q48318647 | Molecular clones of alpha-tubulin genes of Plasmodium yoelii reveal an unusual feature of the carboxy terminus |
Q47933739 | Molecular cloning of Plasmodium yoelii dynamin-like protein (PyDyn) gene and the immunological character of its domains |
Q33600119 | Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites |
Q36446769 | Monoclonal antibodies to stage-specific, species-specific, and cross-reactive antigens of the rodent malarial parasite, Plasmodium yoelii |
Q34945115 | Monoclonal antibody MG96 completely blocks Plasmodium yoelii development in Anopheles stephensi. |
Q47873594 | Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. |
Q47850587 | Morphological analysis of isolated rhoptries from Plasmodium yoelii, P. berghei, and P. chabaudi merozoites |
Q47989252 | Morphological characteristics of Plasmodium yoelii schizonts in ghost erythrocytes |
Q35532141 | Mosquito ingestion of antibodies against mosquito midgut microbiota improves conversion of ookinetes to oocysts for Plasmodium falciparum, but not P. yoelii |
Q48036760 | Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii |
Q48001751 | Multiple genes code for high-molecular-mass rhoptry proteins of Plasmodium yoelii |
Q36552259 | Multivariable analysis of host amino acids in plasma and liver during infection of malaria parasite Plasmodium yoelii |
Q35439705 | Murine complement reduces infectivity of Plasmodium yoelii to mosquitoes |
Q33999883 | Murine gamma delta T lymphocytes elicited during Plasmodium yoelii infection respond to Plasmodium heat shock proteins |
Q36335230 | Murine malaria: blood clearance and organ sequestration of Plasmodium yoelii-infected erythrocytes. |
Q38955721 | MyD88/IL-18-dependent pathways rather than TLRs control early parasitaemia in non-lethal Plasmodium yoelii infection |
Q47874895 | Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection. |
Q37546933 | Myeloperoxidase Attenuates Pathogen Clearance during Plasmodium yoelii Nonlethal Infection |
Q39776648 | NMR solution structure of NBD94(483-502) of the nucleotide-binding domain of the Plasmodium yoelii reticulocyte-binding protein Py235. |
Q38943411 | Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model |
Q34185345 | Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1. |
Q48012328 | Neuropathological studies on Plasmodium yoelii nigeriensis-induced malaria in mice |
Q30595697 | New data on the biology of gametocytes of Plasmodium yoelii yoelli gathered from morphological characteristics indicating their age |
Q87285663 | New orally active amino- and hydroxy-functionalized 11-azaartemisinins and their derivatives with high order of antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice |
Q40783490 | New orally active diphenylmethyl-based ester analogues of dihydroartemisinin: Synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice |
Q50892483 | Nile blue as a stain for exoerythrocytic forms of Plasmodium yoelii. |
Q41914441 | Nitric oxide protects against chloroquine resistant Plasmodium yoelii nigeriensis parasites in vitro |
Q99593443 | Non-lethal Plasmodium yoelii infection drives complex patterns of Th2-type host immunity and mast cell-dependent bacteremia |
Q37542683 | Nonobese Diabetic (NOD) Mice Lack a Protective B-Cell Response against the "Nonlethal" Plasmodium yoelii 17XNL Malaria Protozoan. |
Q46249132 | Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice |
Q103754580 | Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge. |
Q48022885 | Nuclear, Cytosolic, and Surface-Localized Poly(A)-Binding Proteins of Plasmodium yoelii |
Q47922861 | Nucleoside permeation in mouse erythrocytes infected with Plasmodium yoelii |
Q112278643 | Observation of the Gut Microbiota Profile in BALB/c Mice Induced by Plasmodium yoelii 17XL Infection |
Q52519359 | Observation on factors which affect sporogony of Plasmodium yoelii |
Q47876034 | Observation on interleukin-2 in mice infected with Plasmodium yoelii |
Q47931353 | Observation on the susceptibility of Anopheles dirus to Plasmodium yoelii yoelii |
Q44166638 | Observations on the morphology and electrophoretic variation of enzymes of the rodent malaria parasites of Cameroon, Plasmodium yoelii, P. chabaudi and P. vinckei |
Q30352746 | Observed octameric assembly of a Plasmodium yoelii peroxiredoxin can be explained by the replacement of native "ball-and-socket" interacting residues by an affinity tag. |
Q36580383 | One Episode of Self-Resolving Plasmodium yoelii Infection Transiently Exacerbates Chronic Mycobacterium tuberculosis Infection |
Q36488172 | Optimized protocols for improving the likelihood of cloning recombinant progeny from Plasmodium yoelii genetic crosses. |
Q41932647 | Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. |
Q37523912 | Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge |
Q48028150 | Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice |
Q46870293 | Orally active 1,2,4-trioxepanes: synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice |
Q44518924 | Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice |
Q41927656 | Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment |
Q44150298 | Ovary specific immune response during Plasmodium yoelii yoelii infection in malaria vector Anopheles stephensi (Diptera:Insecta). |
Q43217570 | Oxidative Phosphorylation and Rotenone-insensitive Malate- and NADH-Quinone Oxidoreductases in Plasmodium yoelii yoelii Mitochondria in Situ |
Q47985435 | Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages. |
Q107149976 | P183 Induction of the productive immunity against Plasmodium yoelii by MSP1/hsc70 fusion protein vaccine |
Q107149943 | P188 Study of protective antibody epitope in MSP-1 of Plasmodium yoelii yoelii |
Q107149990 | P199 Antimalarial activity of hot-water extract of old or young Dichroa febrifuga leaves in mice infected with Plasmodium yoelii 17XL |
Q107404976 | PSOP1, putative secreted ookinete protein 1, is localized to the micronemes of Plasmodium yoelii and P. berghei ookinetes. |
Q47845696 | Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites |
Q42859360 | Parasite-induced processes for adenosine permeation in mouse erythrocytes infected with the malarial parasite Plasmodium yoelii |
Q35023695 | Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice |
Q48004577 | Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein |
Q30885470 | Partial sequence of sporogony stage-specific 18S ribosomal DNA of Plasmodium yoelii and its application for detection of parasites |
Q35073867 | Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection. |
Q33759208 | Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia |
Q42476677 | Penetration of the mosquito midgut wall by the ookinetes of Plasmodium yoelii nigeriensis |
Q47964233 | Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii |
Q34744509 | Phenotypic dissection of a Plasmodium-refractory strain of malaria vector Anopheles stephensi: the reduced susceptibility to P. berghei and P. yoelii |
Q47924648 | Phosphatidylcholine liposomes as effective adjuvant for vaccination of mice against Plasmodium yoelii |
Q54107291 | Plasmodium berghei and Plasmodium yoelii: molecular karyotypes of drug-resistant lines. |
Q28297465 | Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures |
Q34007632 | Plasmodium falciparum homologue of the genes for Plasmodium vivax and Plasmodium yoelii adhesive proteins, which is transcribed but not translated. |
Q48024749 | Plasmodium vinckei vinckei and P. yoelii nigeriensis: pattern of gametocyte production and development. |
Q36859235 | Plasmodium vinckei vinckei, P. v. lentum and P. yoelii yoelii: chronobiology of the asexual cycle in the blood. |
Q47855890 | Plasmodium vivax reticulocyte binding protein-2 (PvRBP-2) shares structural features with PvRBP-1 and the Plasmodium yoelii 235 kDa rhoptry protein family |
Q91605806 | Plasmodium yoelii 17XL infection modified maturation and function of dendritic cells by skewing Tregs and amplificating Th17 |
Q92479588 | Plasmodium yoelii Erythrocyte-Binding-like Protein Modulates Host Cell Membrane Structure, Immunity, and Disease Severity |
Q47281170 | Plasmodium yoelii S4/CelTOS is important for sporozoite gliding motility and cell traversal |
Q101225506 | Plasmodium yoelii Uses a TLR3-Dependent Pathway to Achieve Mammalian Host Parasitism |
Q31955934 | Plasmodium yoelii YM MAEBL protein is coexpressed and colocalizes with rhoptry proteins. |
Q47975165 | Plasmodium yoelii and Plasmodium berghei: Isolation of infected erythrocytes from blood by colloidal silica gradient centrifugation |
Q40797652 | Plasmodium yoelii and Plasmodium vinckei: the effects of nonspecific immunostimulation on murine malaria |
Q34289829 | Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice. |
Q35927802 | Plasmodium yoelii blood-stage primes macrophage-mediated innate immune response through modulation of toll-like receptor signalling |
Q48013326 | Plasmodium yoelii can ablate vaccine-induced long-term protection in mice |
Q48014112 | Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells |
Q48006599 | Plasmodium yoelii in mice: differential induction of cytokine gene expression during hyporesponsiveness induction and restimulation |
Q55034860 | Plasmodium yoelii infection inhibits murine leukaemia WEHI-3 cell proliferation in vivo by promoting immune responses. |
Q40771114 | Plasmodium yoelii infection of BALB/c mice results in expansion rather than induction of CD4(+) Foxp3(+) regulatory T cells |
Q37533119 | Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development |
Q35867569 | Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development |
Q41921608 | Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice |
Q36211943 | Plasmodium yoelii nigeriensis (N67) Is a Robust Animal Model to Study Malaria Transmission by South American Anopheline Mosquitoes |
Q47884849 | Plasmodium yoelii nigeriensis circumsporozoite gene structure and its implications for the evolution of the repeat regions |
Q36859176 | Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine |
Q44172796 | Plasmodium yoelii nigeriensis: the effect of high and low intensity of infection upon the egg production and bloodmeal size of Anopheles stephensi during three gonotrophic cycles |
Q44137555 | Plasmodium yoelii sporozoite infectivity varies as a function of sporozoite loads in Anopheles stephensi mosquitoes |
Q41189856 | Plasmodium yoelii sporozoites infect CD36-deficient mice |
Q47912949 | Plasmodium yoelii sporozoites infect Syndecan-1 deficient mice |
Q30486620 | Plasmodium yoelii sporozoites modulate cytokine profile and induce apoptosis in murine Kupffer cells |
Q35949795 | Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection |
Q43952470 | Plasmodium yoelii uses the murine Duffy antigen receptor for chemokines as a receptor for normocyte invasion and an alternative receptor for reticulocyte invasion |
Q33883363 | Plasmodium yoelii vitamin B5 pantothenate transporter candidate is essential for parasite transmission to the mosquito |
Q71682290 | Plasmodium yoelii yoelii 17XL MSP-1: fine-specificity mapping of a discontinuous, disulfide-dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR) |
Q35606758 | Plasmodium yoelii yoelii 17XNL constitutively expressing GFP throughout the life cycle |
Q28749151 | Plasmodium yoelii-infected A. stephensi inefficiently transmit malaria compared to intravenous route |
Q25256830 | Plasmodium yoelii17XL infection up-regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellum |
Q48003817 | Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody |
Q47995613 | Plasmodium yoelii: Antibody and the maintenance of immunity in BALB/c mice |
Q59394208 | Plasmodium yoelii: Brefeldin A-Sensitive Processing of Proteins Targeted to the Rhoptries |
Q47973876 | Plasmodium yoelii: Comparison of indirect immunofluorescence and radioimmunoassay for detecting monoclonal antibodies to malaria |
Q56797031 | Plasmodium yoelii: Efficient in Vitro Invasion and Complete Development of Sporozoites in Mouse Hepatic Cell Lines |
Q33213510 | Plasmodium yoelii: a differential fluorescent technique using Acridine Orange to identify infected erythrocytes and reticulocytes in Duffy knockout mouse |
Q41913484 | Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice |
Q37244785 | Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model |
Q43782428 | Plasmodium yoelii: an inbred model for protective immunization against malaria in BALB/c mice |
Q47870976 | Plasmodium yoelii: antibody response in resistant and susceptible mouse strains |
Q45006390 | Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice |
Q40350934 | Plasmodium yoelii: axenic development of the parasite mosquito stages. |
Q47984869 | Plasmodium yoelii: blood oxygen and brain function in the infected mouse |
Q48024323 | Plasmodium yoelii: cellular immune responses in splenectomized and normal mice |
Q47888137 | Plasmodium yoelii: characterization of a protective idiotype during malarial infection in mice |
Q42615642 | Plasmodium yoelii: cloning and characterization of the gene encoding for the mitochondrial heat shock protein 60. |
Q47827967 | Plasmodium yoelii: combinatorial expression of variants of the 235 kDa rhoptry antigen during infection. |
Q47885196 | Plasmodium yoelii: comparative antimalarial activities of dietary fish oils and fish oil concentrates in vitamin E-deficient mice |
Q44172034 | Plasmodium yoelii: contribution of oocysts melanization to natural refractoriness in Anopheles dirus |
Q44152529 | Plasmodium yoelii: correlation of TEP1 with mosquito melanization induced by nitroquine. |
Q44138415 | Plasmodium yoelii: correlation of up-regulated prophenoloxidase and phenoloxidases with melanization induced by the antimalarial, nitroquine. |
Q47831219 | Plasmodium yoelii: differences in the transcription of the 235-kDa rhoptry protein multigene family in lethal and nonlethal lines. |
Q48036669 | Plasmodium yoelii: distinct CD4(+)CD25(+) regulatory T cell responses during the early stages of infection in susceptible and resistant mice |
Q44986318 | Plasmodium yoelii: effects of red blood cell modification and antibodies on the binding characteristics of the 235-kDa rhoptry protein |
Q47826605 | Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum. |
Q48024996 | Plasmodium yoelii: expression of circumsporozoite protein and sporozoite surface protein 2 by sporozoites in culture |
Q47995939 | Plasmodium yoelii: genetic analysis of crosses between two rodent malaria subspecies |
Q44811948 | Plasmodium yoelii: identification and partial characterization of an MDR1 gene in an artemisinin-resistant line |
Q33180333 | Plasmodium yoelii: identification of a gene encoding a putative ADP-ribosylation factor-1 GTPase-activating protein, PyAG1. |
Q77526703 | Plasmodium yoelii: identification of rhoptry proteins using monoclonal antibodies |
Q47924718 | Plasmodium yoelii: induction of attenuated mutants by irradiation |
Q41943456 | Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice |
Q43590437 | Plasmodium yoelii: influence of immune modulators on the development of the liver stage |
Q44725560 | Plasmodium yoelii: novel rhoptry proteins identified within the body of merozoite rhoptries in rodent Plasmodium malaria |
Q47872473 | Plasmodium yoelii: oral delivery of 5-fluoroorotate to treat malaria in mice |
Q48034036 | Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein |
Q68193864 | Plasmodium yoelii: quantification of the exoerythrocytic stages based on the use of ribosomal RNA probes |
Q48036937 | Plasmodium yoelii: resistance to disease is linked to the mtv-7 locus in BALB/c mice |
Q39010447 | Plasmodium yoelii: semiquantitative analyses of circumsporozoite protein gene expression during the sporogonic development of P. y. yoelii and P. y. nigeriensis in the mosquito vector Anopheles stephensi. |
Q48024315 | Plasmodium yoelii: splenectomy alters the antibody responses of infected mice |
Q39188894 | Plasmodium yoelii: the effect of second blood meal and anti-sporozoite antibodies on development and gene expression in the mosquito vector, Anopheles stephensi. |
Q48026805 | Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria |
Q47989437 | Plasmodium yoelii: the thymus-dependent lymphocyte in mice immunodepressed by malaria |
Q41928186 | Poly ICLC enhances the antimalarial activity of chloroquine against multidrug-resistant Plasmodium yoelii nigeriensis in mice |
Q35854390 | Polysaccharides from the Chinese medicinal herb Achyranthes bidentata enhance anti-malarial immunity during Plasmodium yoelii 17XL infection in mice |
Q43034329 | Possibility of false-positive detection for sporozoites in mosquitos (Diptera: Culicidae) by nested polymerase chain reaction using Plasmodium yoelii genomic DNA. |
Q33378497 | Possible involvement of platelets in Plasmodium yoelii nigeriensis malaria infection in mice |
Q46334941 | Postnatal development and resistance to Plasmodium yoelii infection of mice prenatally exposed to triphenyltin hydroxide. |
Q48285252 | Precursor to the major merozoite surface antigen of Plasmodium yoelii: cloning and sequencing of the middle 1.9-kb region |
Q35784187 | Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells |
Q43596822 | Proceedings: The passive transfer of immunity to Plasmodium berghei yoelii |
Q47923216 | Production and characterization of monoclonal antibodies against asexual stages of Plasmodium yoelii nigeriensis |
Q39142470 | Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii |
Q46135249 | Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1. |
Q41123106 | Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice |
Q47854195 | Prolonged expression of IFNgamma induced by protective blood-stage immunization against Plasmodium yoelii malaria |
Q112708636 | Properties and Roles of γδT Cells in Plasmodium yoelii nigeriensis NSM Infected C57BL/6 Mice |
Q39540836 | Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii |
Q48037311 | Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice |
Q91857340 | Prophylactic treatment of L-Arg improves malaria outcomes by regulating host immune responses during Plasmodium yoelii 17XL infection |
Q41919977 | Protection against Plasmodium berghei yoelii in chloroquine- and pyrimethamine-treated mice. |
Q48033332 | Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes |
Q48007496 | Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine |
Q33757015 | Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines |
Q47983607 | Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii |
Q42415030 | Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection |
Q28345224 | Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region |
Q39830589 | Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens |
Q36920493 | Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii |
Q47892490 | Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yo |
Q31920489 | Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes. |
Q27972573 | Proteome mapping of Plasmodium: identification of the P. yoelii remodellome |
Q47837790 | Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. |
Q53595066 | Purification and biochemical characterization of cytosolic glutathione-S-transferase from malarial parasites Plasmodium yoelii. |
Q59977418 | Purification and characterization of Plasmodium yoelii adenosine deaminase |
Q43145904 | Pyrimethamine induces oxidative stress in Plasmodium yoelii 17XL-infected mice: a novel immunomodulatory mechanism of action for an old antimalarial drug? |
Q47898085 | Qinghaosu, dietary vitamin E, selenium, and cod-liver oil: effect on the susceptibility of mice to the malarial parasite Plasmodium yoelii |
Q34674176 | Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii |
Q33883479 | Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes |
Q47997425 | Radioimmunoassay for detecting antibodies against murine malarial parasite antigens: monoclonal antibodies recognizing Plasmodium yoelii antigens. |
Q33403264 | Rapid changes in transcription profiles of the Plasmodium yoelii yir multigene family in clonal populations: lack of epigenetic memory? |
Q47890552 | Rapid clearance of Plasmodium yoelii-infected erythrocytes after exposure to the ionophore A23187. |
Q37016743 | Rapid parasite multiplication rate, rather than immunosuppression, causes the death of mice infected with virulent Plasmodium yoelii. |
Q40864343 | Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria |
Q47876758 | Reduced antibody response to the repetitive sequence of the Plasmodium falciparum circumsporozoite protein in mice infected with Plasmodium yoelii blood forms |
Q34114245 | Regional immunosuppression induced by Plasmodium berghei yoelii infection in mice |
Q35677570 | Regulation of Plasmodium yoelii oocyst development by strain- and stage-specific small-subunit rRNA |
Q21131602 | Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature |
Q41481133 | Remarkable stability in patterns of blood-stage gene expression during episodes of non-lethal Plasmodium yoelii malaria |
Q48020021 | Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection. |
Q43952353 | Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis |
Q41621678 | Retarded schizogony of Plasmodium yoelii yoelii in rodents treated with ethionine or subjected to a methionine deficiency: histological and ultrastructural studies |
Q44598541 | Retrieving parasite specific liver stage gene products in Plasmodium yoelii infected livers using differential display. |
Q43557981 | Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge |
Q91674729 | Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious Plasmodium yoelii |
Q44154550 | Rodent plasmodia of the République Centrafricaine: the sporogony and tissue stages of Plasmodium chabaudi and P. berghei yoelii |
Q47831678 | Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection. |
Q48018572 | Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. |
Q36966793 | Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites |
Q36868795 | Role of macrophages as possible transporters of Plasmodium yoelii nigeriensis merozoites through the lymphatic system. Preliminary note |
Q40178820 | Role of macrophages in malaria: O2 metabolite production and phagocytosis by splenic macrophages during lethal Plasmodium berghei and self-limiting Plasmodium yoelii infection in mice |
Q47853595 | Roles of T cell subsets in the protective immunity of mice against Plasmodium yoelii |
Q27973415 | SSP3 is a novel Plasmodium yoelii sporozoite surface protein with a role in gliding motility |
Q36177240 | STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria. |
Q44165892 | Scanning electron microscopic observations of the oocyst, sporoblast and sporozoite of Plasmodium yoelii yoelii. |
Q48023461 | Schistosoma mansoni infection suppresses the growth of Plasmodium yoelii parasites in the liver and reduces gametocyte infectivity to mosquitoes. |
Q36747038 | Schizogony of Plasmodium yoelii nigeriensis. Role of latent merozoites |
Q44142150 | Selection of Anopheles dirus for refractoriness and susceptibility to Plasmodium yoelii nigeriensis |
Q54382441 | Selection of Plasmodium yoelii nigeriensis resistant to triple drug combination (sulphadoxine/pyrimethamine/mefloquine) and its response to other antimalarials. |
Q30877681 | Sequence analysis of the Rhop-3 gene of Plasmodium yoelii |
Q48063454 | Sequence analysis of the apical membrane antigen-1 genes (ama-1) of Plasmodium yoelii yoelii and Plasmodium berghei |
Q45269413 | Sequence analysis upstream of the gene encoding the precursor to the major merozoite surface antigens of Plasmodium yoelii |
Q48378835 | Sequence diversity and antigenic polymorphism in the Plasmodium yoelii p235 high molecular mass rhoptry proteins and their genes |
Q48076838 | Sequence of the gene encoding the N-terminal portion of the Plasmodium yoelii yoelii 17XL merozoite surface protein-1 (MSP-1). |
Q47248895 | Serological cross-reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum |
Q39860521 | Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth |
Q37182642 | Single amino acid substitution in Plasmodium yoelii erythrocyte ligand determines its localization and controls parasite virulence |
Q47910135 | Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis |
Q31063140 | Single-chain antibodies produced by phage display against the C-terminal 19 kDa region of merozoite surface protein-1 of Plasmodium yoelii reduce parasite growth following challenge |
Q43685080 | Soluble protein and esterase isozyme analysis of adult female Anopheles stephensi after Plasmodium yoelii yoelii-infected blood meal |
Q47909878 | Some studies on acquired immunity to Plasmodium chabaudi and Plasmodium yoelii in mice |
Q47866590 | Spatial and temporal dynamics of the secretory pathway during differentiation of the Plasmodium yoelii schizont |
Q47857895 | Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites |
Q47988720 | Specific lysis of Plasmodium yoelii infected mouse erythrocytes with antibody and complement |
Q47924840 | Spleen cell antibody-dependent cell-mediated cytotoxicity (ADCC) in mice infected with Plasmodium yoelii yoelii |
Q59010675 | Spontaneous Resistance to Chloroquine in a Strain of Rodent Malaria (Plasmodium berghei yoelii) |
Q44170530 | Sporogonic development of Plasmodium yoelii in five anopheline species |
Q48037250 | Sporozoites of Plasmodium yoelii infect mice with targeted deletions in ICAM-1 and ICAM-2 or complement components C3 and C4. |
Q47854247 | Stage-specific expression of heat shock protein 90 in murine malaria parasite Plasmodium yoelii |
Q52279216 | Staining of Plasmodium yoelii-infected mouse erythrocytes with the fluorescent dye rhodamine 123. |
Q42545049 | Status of ammonia, glutamate, lactate and pyruvate during Plasmodium yoelii infection and pyrimethamine treatment in mice. |
Q41941767 | Status of hepatic heme and heme oxygenase during Plasmodium yoelii nigeriensis infection in mice |
Q41921924 | Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice |
Q47829968 | Status of urea and related enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice. |
Q35585556 | Strain-specific spleen remodelling in Plasmodium yoelii infections in Balb/c mice facilitates adherence and spleen macrophage-clearance escape. |
Q48008364 | Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection |
Q27659886 | Structural Determination of Functional Units of the Nucleotide Binding Domain (NBD94) of the Reticulocyte Binding Protein Py235 of Plasmodium yoelii |
Q27658580 | Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host |
Q38033382 | Structural architecture and interplay of the nucleotide- and erythrocyte binding domain of the reticulocyte binding protein Py235 from Plasmodium yoelii |
Q38686466 | Structural characterization of the erythrocyte binding domain of the reticulocyte binding protein homologue family of Plasmodium yoelii |
Q33875497 | Structure of a Plasmodium yoelii gene-encoded protein homologous to the Ca(2+)-ATPase of rabbit skeletal muscle sarcoplasmic reticulum. |
Q47829075 | Structure of the E8 gene encoding a high molecular mass rhoptry protein of Plasmodium yoelii. |
Q47908054 | Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines |
Q44165145 | Studies of antigens in Plasmodium yoelii. I. Antigenic differences between parasite lines detected by crossed immunoelectrophoresis |
Q44187028 | Studies of antigens in Plasmodium yoelii. II. Inheritance and recombination of antigenic characters |
Q128011678 | Studies of effector cells and MHC class II in mouse infected with erythrocytic stage of plasmodium yoelii |
Q47946335 | Studies of splenomegaly in rodent malaria III. Protein calorie malnutrition and splenomegaly in mice infected with Plasmodium berghei yoelii |
Q47967847 | Studies of splenomegaly in rodent malaria. I. The course of splenomegaly in mice infected with Eperythrozoon coccoides, plasmodium berghei yoelii and the two infections combined |
Q47743694 | Studies of splenomegaly in rodent malaria. II. The course of splenomegaly, IgM, IgG levels and IgG immunofluorescent antibody titre in mice after infection with Plasmodium berghei yoelii and-or Plasmodium chabaudi |
Q48037567 | Studies of the hepatic mitochondrial and microsomal mixed-function oxidase system during Plasmodium yoelii infection and inducer treatment in Swiss albino mice |
Q48030930 | Studies on ammonia-metabolizing enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice |
Q47995786 | Studies on antimalarial drug. II. The causal prophylactic activity of antimalarial in animal model. Part I. Plasmodium yoelii-Anopheles stephensi system (author's transl) |
Q48028103 | Studies on drug metabolizing enzymes during arteether treatment of Plasmodium yoelii nigeriensis infected mice cerebral microvessels |
Q40903378 | Studies on enzyme variation in the murine malaria parasites Plasmodium berghei, P. yoelii, P. vinckei and P. chabaudi by starch gel electrophoresis |
Q44087166 | Studies on erythrocytic methemoglobin reductase systems in Plasmodium yoelii nigeriensis infected mice |
Q47865098 | Studies on hepatic mitochondrial cytochrome P-450 during Plasmodium yoelii infection and pyrimethamine treatment in mice |
Q41923793 | Studies on hepatic oxidative stress and antioxidant defence system during chloroquine/poly ICLC treatment of Plasmodium yoelii nigeriensis infected mice |
Q47851562 | Studies on hepatic oxidative stress and antioxidant defence systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice |
Q47984874 | Studies on the antigens of invasive stages of Plasmodium yoelii and Plasmodium berghei |
Q44514543 | Studies on the effective components in protective sera against Plasmodium yoelii infections in mice |
Q107149539 | Study for the detection of rodent malaria parasites (Plasmodium yoelii nigeriensis) in mosquitoes |
Q47836660 | Study of gametocytes from the Plasmodium "vivax" group: morphology, development in Anopheles and infectivity of Plasmodium yoelii microgametocytes |
Q72968621 | Study of the cycle of Plasmodium berghei yoelii in view of the massive production of viable sporozoites and exo-erythrocytary forms |
Q48033212 | Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice. |
Q47877856 | Study on the exoerythrocytic forms of Plasmodium yoelii yoelii in rats and mice |
Q30970902 | Study on the relationship between intracellular free calcium and melanization in oocysts of Plasmodium yoelii |
Q35791168 | Sub-cellular localization and post-translational modifications of the Plasmodium yoelii enolase suggest moonlighting functions |
Q44140691 | Sudden increase in virulence in a strain ofPlasmodium berghei yoelii |
Q48012994 | Supplement of L-Arg improves protective immunity during early-stage Plasmodium yoelii 17XL infection |
Q47852352 | Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection |
Q33711883 | Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii. |
Q47994319 | Survival of mice injected with Plasmodium vinckei or Plasmodium yoelii XL by the footpad route. |
Q44166487 | Susceptibility of Anopheles gambiae to Plasmodium yoelii nigeriensis and Plasmodium falciparum. |
Q107152825 | Susceptibility of Anopheles omorii to Plasmodium yoelii nigeriensis |
Q57023418 | Susceptibility of Species A, B, and C of Anopheles culicifacies Complex to Plasmodium yoelii yoelii and Plasmodium vinckei petteri Infections |
Q44144881 | Susceptibility of species A, B, and C of Anopheles culicifacies complex to Plasmodium yoelii yoelii and Plasmodium vinckei petteri infections |
Q44147676 | Susceptibility of the mosquitoes Anopheles minimus, An. sinensis, and An. saperoi (Diptera: Culicidae) from the Ryukyu Archipelago, Japan, to the rodent malaria Plasmodium yoelii nigeriense |
Q107153489 | Susceptibility of three species of Anopheles from Okinawa to the rodent malaria Plasmodium yoelii nigeriense |
Q29031063 | Susceptibility to Plasmodium yoelii Preerythrocytic Infection in BALB/c Substrains Is Determined at the Point of Hepatocyte Invasion |
Q36752160 | Synchronization of Plasmodium yoelii nigeriensis and P. y. killicki infection in the mouse by means of Percoll-glucose gradient stage fractionation: determination of the duration of the schizogonic cycle |
Q44137540 | Synchronized Plasmodium yoelii yoelii: pattern of gametocyte production, sequestration and infectivity. |
Q48002598 | Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria |
Q47974679 | System model of Plasmodium yoelii--Anopheles stephensi for screening tissue schizontocides |
Q46242678 | Systematic CRISPR-Cas9-Mediated Modifications of Plasmodium yoelii ApiAP2 Genes Reveal Functional Insights into Parasite Development |
Q92863003 | T Cell-Specific Overexpression of Acid Sphingomyelinase Results in Elevated T Cell Activation and Reduced Parasitemia During Plasmodium yoelii Infection |
Q47989582 | T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii. |
Q33614847 | T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s) |
Q37036676 | T-cell-mediated immune response in murine malaria: differential effects of antigen-specific Lyt T-cell subsets in recovery from Plasmodium yoelii infection in normal and T-cell-deficient mice |
Q39373068 | TLR4 and TLR9 signals stimulate protective immunity against blood-stage Plasmodium yoelii infection in mice |
Q33838368 | Targeted disruption of py235ebp-1: invasion of erythrocytes by Plasmodium yoelii using an alternative Py235 erythrocyte binding protein |
Q47867594 | The 235 kD rhoptry protein of Plasmodium yoelii |
Q34365299 | The 235 kDa rhoptry protein of Plasmodium (yoelii) yoelii: function at the junction. |
Q37483845 | The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody |
Q90137873 | The C-terminal region of the Plasmodium yoelii microgamete surface antigen PyMiGS induces potent anti-malarial transmission-blocking immunity in mice |
Q47890164 | The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine |
Q33553648 | The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection |
Q99931032 | The Morphological Characteristics of Plasmodium yoelii Gametocytogenesis |
Q59923959 | The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes |
Q40153756 | The Transcription Factor NFAT1 Participates in the Induction of CD4+ T Cell Functional Exhaustion during Plasmodium yoelii Infection. |
Q41776885 | The action of metabolic inhibitors on microgametogenesis in Plasmodium yoelii nigeriensis |
Q41932192 | The antiplasmodial effect of the extracts and formulated capsules of Phyllanthus amarus on Plasmodium yoelii infection in mice. |
Q47917507 | The chemotherapy of rodent malaria XLI. Causal prophylaxis. Part V. Effect of mefloquine on exoerythrocytic schizogony in Plasmodium yoelii yoelii |
Q36610997 | The chemotherapy of rodent malaria XXXVI. Part IV. The activity of a new 8-aminoquinoline, WR 225,448 against exo-erythrocytic schizonts of Plasmodium yoelii yoelii |
Q41931865 | The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening |
Q44166868 | The chemotherapy of rodent malaria, XXXII. The influence of p-aminobenzoic acid on the transmission of Plasmodium yoelii and P. berghei by Anopheles stephensi. |
Q44164768 | The chemotherapy of rodent malaria, XXXIV. Causal prophylaxis Part III: Ultrastructural changes induced in exo-erythrocytic schizonts of Plasmodium yoelii yoelii by primaquine |
Q41932432 | The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers. |
Q47998652 | The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite |
Q43644634 | The course of Plasmodium berghei, P. chabaudi and P. yoelii infections in beta-thalassaemic mice |
Q48004075 | The course of a primary infection of Plasmodium yoelii 17XL in both 129S1 and IFN-γ receptor-deficient mice |
Q47961790 | The course of malarial infection, caused by different strains of Plasmodium berghei yoelii Landau and Killick-Kendrick, 1966 |
Q48021711 | The domain on the mouse Duffy protein for Plasmodium yoelii binding and invasion to mouse erythrocytes |
Q44174997 | The effect of Plasmodium yoelii nigeriensis infection on ovarian protein accumulation by Anopheles stephensi |
Q52174016 | The effect of Plasmodium yoelii nigeriensis infection on the feeding persistence of Anopheles stephensi Liston throughout the sporogonic cycle. |
Q47890342 | The effect of pentostam and cimetidine on the development of leishmaniasis (Leishmania mexicana amazonensis) and concomitant malaria (Plasmodium yoelii). |
Q44142788 | The effects of Nosema algerae on the development of Plasmodium yoelii nigeriensis in Anopheles stephensi |
Q39092407 | The effects of chloroquine on the infectivity of chloroquine-sensitive and -resistant populations of Plasmodium yoelii nigeriensis to mosquitoes |
Q47883063 | The effects of host diet on Plasmodium yoelii nigeriensis |
Q44137683 | The effects of infection with Plasmodium yoelii nigeriensis on the reproductive fitness of Anopheles stephensi |
Q127813431 | The expression of host derived 65KD heat shock protein closely correlates with protective immunity to plasmodium yoelii infection in mice |
Q39395136 | The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)). |
Q47896181 | The high molecular mass rhoptry protein, RhopH1, is encoded by members of the clag multigene family in Plasmodium falciparum and Plasmodium yoelii |
Q44151591 | The infectivity of Plasmodium yoelii in different strains of mice |
Q44173638 | The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes |
Q41927588 | The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo |
Q68029496 | The plasma membrane and mitochondrial membrane potentials of Plasmodium yoelii |
Q71486258 | The purification of gametocytes of Plasmodium falciparum and P. yoelii nigeriensis by colloidal silica (Percoll) gradient centrifugation |
Q47951793 | The quantitative analysis of effects of exogenous and endogenous factors on sporozoites and tissue forms of malaria in small animals (Plasmodium cathemerium, P. berghei yoelii) |
Q41296523 | The ratio of Treg/Thl7 cells from mice infected with Plasmodium yoelii in the early stage of infection |
Q47989557 | The rodent malaria parasite Plasmodium yoelii lacks both types 1 and 2 T-independent antigens. |
Q47903467 | The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA. |
Q34698064 | The role of serine-type serine repeat antigen in Plasmodium yoelii blood stage development |
Q27681234 | The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design |
Q27333248 | Time-lapse imaging of red blood cell invasion by the rodent malaria parasite Plasmodium yoelii |
Q47871949 | Tissue schizontocidal effect of trifluoroacetyl primaquine in Plasmodium yoelii infected mice and Plasmodium cynomolgi infected monkeys |
Q42628729 | Transcription and alternative splicing in the yir multigene family of the malaria parasite Plasmodium y. yoelii: identification of motifs suggesting epigenetic and post-transcriptional control of RNA expression |
Q31170352 | Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression |
Q28473729 | Transcriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoelii |
Q30765385 | Transcriptome of axenic liver stages of Plasmodium yoelii |
Q34522415 | Transgenic mice expressing C-reactive protein are susceptible to infection with Plasmodium yoelii sporozoites |
Q47898338 | Transport processes of 2-deoxy-D-glucose in erythrocytes infected with Plasmodium yoelii, a rodent malaria parasite |
Q44142314 | Trials to infect Anopheles stephensi with Plasmodium yoelii nigeriensis by the membrane feeding technique |
Q44151026 | Trypsin and aminopeptidase activities in blood-fed females Anopheles dirus (Diptera: Culicidae) of differing susceptibility to Plasmodium yoelii nigeriensis. |
Q35211483 | Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion |
Q35549265 | Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity |
Q44167876 | Two serine proteases from Anopheles dirus haemocytes exhibit changes in transcript abundance after infection of an incompatible rodent malaria parasite, Plasmodium yoelii. |
Q36087778 | Typing Plasmodium yoelii microsatellites using a simple and affordable fluorescent labeling method |
Q35899369 | UTR introns, antisense RNA and differentially spliced transcripts between Plasmodium yoelii subspecies. |
Q71380755 | Ultrastructural localization of protective antigens of Plasmodium yoelii merozoites by the use of monoclonal antibodies and ultrathin cryomicrotomy |
Q33735095 | Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin |
Q37028364 | Use of a two-sited monoclonal antibody assay to detect a heat-stable malarial antigen in the sera of mice infected with Plasmodium yoelii |
Q47931397 | Utility of the dried blood on filter paper as a source of cytokine mRNA for the analysis of immunoreactions in Plasmodium yoelii infection |
Q44167074 | Vaccination to prevent transmission of Plasmodium yoelii malaria |
Q41337172 | Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage |
Q92149824 | Validation of Plasmodium vivax centromere and promoter activities using Plasmodium yoelii |
Q94491616 | Vancomycin improves Plasmodium yoelii malaria parasite in vitro liver stage cultures by controlling Elizabethkingia anophelis, a bacterium in the microbiome of lab-reared Anopheles mosquitoes |
Q47836547 | Variable expression of the 235 kDa rhoptry protein of Plasmodium yoelii mediate host cell adaptation and immune evasion |
Q44168031 | Variable expression of virulence in the rodent malaria parasite Plasmodium yoelii yoelii |
Q47930536 | Virulence of plasmodium yoelii line YM is caused by altered preference for parasitized and unparasitized immature and mature erythrocytes |
Q37081468 | Virulent and nonvirulent forms of Plasmodium yoelii are not restricted to growth within a single erythrocyte type |
Q35533780 | Vitamin E-deficient diets enriched with fish oil suppress lethal Plasmodium yoelii infections in athymic and scid/bg mice |
Q35556647 | Within-host competition does not select for virulence in malaria parasites; studies with Plasmodium yoelii |
Q36378809 | Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection |
Q67273623 | [A simple method for isolating Plasmodium yoelii] |
Q67510450 | [Blood relapses and modifications of the pre-erythrocytic shizonts of Plasmodium yoelii using ethionine] |
Q93630474 | [Concentration and isolation of schizonts and merozoites of Plasmodium yoelii yoelii] |
Q71581182 | [Development of schizonts in cultured hepatocytes of adult rats after in vitro infection with Plasmodium yoelii sporoazoites] |
Q68069822 | [Effect of Poly I:C on the sporozoite invasion and the development of exoerythrocytic forms of Plasmodium yoelii yoelii in rats] |
Q67838613 | [Effect of alpha-difluoromethylornithine on sporogony of Plasmodium yoelii] |
Q52677913 | [Effect of anti-midgut-protein-ingredient antibodies of Anopheles stephensi on the oocysts of Plasmodium yoelii]. |
Q52603071 | [Effect of anti-mosquito-midgut antibodies on the development of oocysts of Plasmodium yoelii in Anopheles stephensi] |
Q67881214 | [Effect of nitroquine on protein synthesis of Plasmodium yoelii in vitro] |
Q70583968 | [Effect of pyronaridine and three other antimalarials on gametocytes and sporogony of Plasmodium yoelii] |
Q72400047 | [Effect of some factors on the development of exoerythrocytic stage of Plasmodium yoelii] |
Q68699370 | [Effects of cyclophosphamide on the development of exo-erythrocytic forms of Plasmodium yoelii in rats] |
Q67950625 | [Effects of pyrimethamine on the oocyst formation of Plasmodium yoelii yoelii] |
Q70363937 | [In vitro infection of adult Thamnomys hepatocytes by sporozoites of Plasmodium yoelii: development of schizonts and release of infective merozoites] |
Q71627844 | [In vitro infestation of adult thamnomys hepatocytes with Plasmodium yoelii sporozoites; schizogony and release of infecting merozoites] |
Q83194586 | [Inhibition of Plasmodium yoelii circumsporozoite protein on the activation of nuclear transcription factor in hepatoma cells stimulated by TNF-alpha] |
Q68899630 | [Isoenzyme typing of strains of Plasmodium berghei and Plasmodium yoelii] |
Q67904731 | [Localization of the antigen in erythrocytic stages of Plasmodium yoelii by immuno-electron microscopy] |
Q50559854 | [Recombinant Plasmodium yoelii expressing green fluorescent protein in erythrocytic and mosquito stages]. |
Q52603046 | [Relationship between hemolymph phenol oxidase and melanization of oocysts of Plasmodium yoelii in Anopheles stephensi] |
Q69695220 | [Scanning electron microscopic observations of ookinete formation of Plasmodium yoelii yoelii in vitro] |
Q68081419 | [Some ultrastructural characteristics of Plasmodium yoelii yoelii in erythrocytic schizogony and gametocytosis] |
Q91077511 | [The effect of leptin transgenic Plasmodium yoelii on mouse body weight] |
Q91077474 | [The regulatory effect of dendritic cells on Th17 cell differentiation and function in mouse infected with Plasmodium yoelii] |
Q69422557 | [Ultrastructural study on effect of primaquine on sporogonic stage of Plasmodium yoelii nigeriensis] |
Q114143176 | cAMP-dependent protein kinase regulates secretion of apical membrane antigen 1 (AMA1) in Plasmodium yoelii |
Q47849942 | gamma delta T-cells may interfere with a productive immune response in Plasmodium yoelii infections |
Q61779086 | Plasmodium yoelii 17X | parent taxon | P171 |
Category:Plasmodium yoelii | wikimedia | |
Plasmodium yoelii | wikimedia | |
Plasmodium yoelii | wikipedia | |
Plasmodium yoelii | wikipedia | |
Plasmodium yoelii | wikipedia |
Search more.